AG00I94W

51-42-3 | 1,​2-​Benzenediol, 4-​[(1R)​-​1-​hydroxy-​2-​(methylamino)​ethyl]​-​, (2R,​3R)​-​2,​3-​dihydroxybutanedioat​e (1:1)

Chemical structure of 1,​2-​Benzenediol, 4-​[(1R)​-​1-​hydroxy-​2-​(methylamino)​ethyl]​-​, (2R,​3R)​-​2,​3-​dihydroxybutanedioat​e (1:1), CAS 51-42-3
AG00I94W
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 51-42-3
Catalog Number AG00I94W(AGN-PC-0SAJLQ)
Chemical Name 1,​2-​Benzenediol, 4-​[(1R)​-​1-​hydroxy-​2-​(methylamino)​ethyl]​-​, (2R,​3R)​-​2,​3-​dihydroxybutanedioat​e (1:1)
EC Number 200-097-1
IUPAC Name (2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
InChI InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
InChI Key YLXIPWWIOISBDD-NDAAPVSOSA-N
MDL Number MFCD00035077
Molecular Formula C13H19NO9
Molecular Weight 333.2913
SMILES O[C@@H](C(=O)O)[C@H](C(=O)O)O.O[C@@H](CNC)C=1C=C(C(=CC1)O)O
UNII 30Q7KI53AK
Synonyms
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol, Acetate, Epinephrine, Adrenaline, Adrenaline Acid Tartrate, Adrenaline Bitartrate, Adrenaline Hydrochloride, Epifrin, Epinephrine, Epinephrine Acetate, Epinephrine Bitartrate, Epinephrine Hydrochloride, Epinephrine Hydrogen Tartrate, Epitrate, Lyophrin, Medihaler-Epi, Epinephrine bitartrate, 51-42-3, Epinephrine acid tartrate, Bronitin Mist, Adrenaline acid tartrate, Adrenalinetartrate, Adrenaline bitartrate, L-Adrenaline tartrate, l-Epinephrine tartrate, Asthmahaler, Epinephrine d-bitartrate, Bronkaid Mist Suspension, l-Adrenaline bitartrate, (-)-Adrenaline tartrate, l-Adrenaline d-bitartrate, Primatene Mist Suspension, l-Epinephrine bitartrate, l-Epinephrine d-bitartrate, EPINEPHRINE TARTRATE, (-)-Adrenaline bitartrate, Adrenaline tatrate, Adrenaline hydrogen tartrate, L-Epinephrine (Bitartrate), adrenaline tartrate, UNII-30Q7KI53AK, Adrenaline acid tartrate, l-, (-)-Adrenaline acid tartrate, l-Adrenaline hydrogen tartrate, (-)-Adrenaline hydrogen tartrate, (R)-(-)-Epinephrine bitartrate, (-)-Epinephrine (+)-bitartrate, EINECS 200-097-1, D02149, 30Q7KI53AK, (-)-Epinephrine bitartrate, Epinephrine hydrogen tartrate, Epinephrine bitartrate (Adrenalinium), 24351-82-4, (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt, (R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate, 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-, L-Adrenalin Bitartrate, (2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt), Bronitin, (-)-Epinephrine (+)-bitartrate salt, Epinephrine bitartrate [USP:JAN], Epinephrine bitartrate [USAN:JAN], (2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, Asmatane mist (TN), Medihaler-epi (TN), epinephrinehydrogentartrate, (-)-3,4-dihydroxy-a-((methylamino)methyl)benzyl alcohol(+)-tartrate(1:1) salt, DSSTox_CID_29375, DSSTox_RID_83490, DSSTox_GSID_49415, L-tartaric acid; epinephrine, SCHEMBL40741, AC1L1L78, AC1Q5R39, CHEMBL1200818, DTXSID3049415, HY-B0447A, L(+)-tartaric acid; epinephrine, Epinephrine bitartrate (JAN/USP), Tox21_202839, s2521, AKOS015951390, BCP9000650, CS-2557, CAS-51-42-3, NCGC00260385-01, AN-24393, BC677071, LS-42887, BCP0726000242, AB1009544, Adrenaline Tartrate (L-Adrenaline Tartrate), (-)-Epinephrine (+)-bitartrate salt, solid, ST50409530, SW219274-2, (-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur., Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard, Adrenaline acid tartrate, British Pharmacopoeia (BP) Reference Standard, Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard, Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard, Epinephrine Bitartrate, Pharmaceutical Secondary Standard; Certified Reference Material, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, (2R,3R)-2,3-dihydroxy butanedioic acid, Suprarenin, Epitrate, Asmatane Mist, Medihaler-Epi, Sensorcaine, Duranest, Lyophrin, Vivacaine, Citanest Forte, Mixture Name, E-Pilo, Epinefrina tartrato, adrenalin bitartrate, LIGNOSPAN FORTE, epinephrinhydrogentartrat-, LIGNOSPAN STANDARD, L-ADRENALINEBITARTRATE, R-(-)-Epinephrine bitartrate, C9H13NO3, C9H13NO3.C4H6O6, CID5815, KST-1A0318, MARCAINE HCL W/ EPINEPHRINE, Adrenaline BiTartrate 99% AR 1gm, Adrenaline tartrate (1:1) (6CI), AR-1A0047, Adrenalina, tartrato (01:01) (6CI), (R)-(+)-2-Amino-4-hydroxybutyric acid, C9-H13-N-O3.C4-H6-O6, Tartaric acid compd. with adrenaline (6CI), Epinephrine Bitartrate/Adrenaline Acid Tartrate, MARCAINE HCL W/ EPINEPHRINE PRESERVATIVE FREE, (-)-Epinephrine ( )-bitartrate salt, 98% - 1G 1g, 10036-09-6, 1,2-benzenediol, 4-[(1R)-1-hidroxi-2-(metilamino) etil]-, (2R, 3R)-2,3-dihidroxibutanedioate (1:1) (sal) (9CI), 1,2-benzenediol, 4-[(1R)-1-hidroxi-2-(metilamino) etil]-, (2R, 3R)-2,3-dihidroxibutanodioato (1:1), 1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt), 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-, [R-(R,R)]-2,3-dihydroxybutanedioate (1:1) (salt), 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt), 12-Benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-(2R3R)-23-dihydroxybutanedioate (1:1) (salt) (9CI), 12-Benzenediol 4-[1-hydroxy-2-(methylamino)ethyl]-(R)-[R-(R*R*)]-23-dihydroxybutanedioate (1:1) (salt), 16536-89-3, Benzyl alcohol 3 4-dihydroxy-alpha-[(methylamino)methyl]-(-)-(+)-tartrate (1:1) (salt) (8CI),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited